These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4890905)

  • 1. Allogeneic canine bone marrow transplantation following cyclophosphamide.
    Storb R; Epstein RB; Rudolph RH; Thomas ED
    Transplantation; 1969 May; 7(5):378-86. PubMed ID: 4890905
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone marrow chimeras in man and animals.
    Thomas ED; Storb R; Epstein RB
    Hamatol Bluttransfus; 1970; 9():86-95. PubMed ID: 4396279
    [No Abstract]   [Full Text] [Related]  

  • 3. [Change in mouse peripheral blood during specific and combined suppression of transplantation immunity].
    Shatalova IN; Nastoiashchaia NN; Artsimovich NG; Sergel' OS
    Dokl Akad Nauk SSSR; 1973; 210(6):1450-2. PubMed ID: 4578780
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of cyclophosphamide and antilymphocytic serum on the cellular reactions to homologous skin implanted into brain.
    Ridley A
    Acta Neuropathol; 1970; 15(4):351-8. PubMed ID: 4916008
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppressive effects of cyclophosphamide and L-asparaginase in the inbred rat renal transplant model.
    Levin B; Merrill JP
    Transplantation; 1972 Feb; 13(2):160-3. PubMed ID: 4550990
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunosuppressive effect of histone on the model of skin transplantation. Comparative studies with cyclophosphamide].
    Gillissen G
    Z Gesamte Exp Med Einschl Exp Chir; 1970 Aug; 152(4):335-51. PubMed ID: 4930364
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotherapy in immunosuppression and transplantation].
    Málek P
    Cas Lek Cesk; 1972 Nov; 111(45):1044. PubMed ID: 5084843
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the effects of immunosuppressive and cytostatic substances on the oxidative metabolism of leukocytes during the rejection of kidney homotransplants].
    Păuşescu E; Dincă A; Chirvasie R
    Z Gesamte Inn Med; 1968 Jan; 23(2):33-7. PubMed ID: 4879774
    [No Abstract]   [Full Text] [Related]  

  • 9. Kidney transplantation following treatment with cyclophosphamide and bone marrow grafting.
    von Scheel J; Kolb HJ; Duswald KH; Rieder I; Chaussy C; Grosse-Wilde H; Scholz S; Pielsticker K
    Transplant Proc; 1977 Mar; 9(1):261-3. PubMed ID: 325763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of canine graft-versus-host disease with methotrexate and cyclo-phosphamide following bone marrow transplantation from histoincompatible donors.
    Storb R; Graham TC; Shiurba R; Thomas ED
    Transplantation; 1970 Aug; 10(2):165-72. PubMed ID: 4393683
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of PCO (yeast respiratory stimulator) on treated and untreated dog renal allografts.
    Murphy GP; Mirand EA; Williams PD; Gaeta JF; Groenewald JH; Kenny GM; Grace JT
    J Surg Oncol; 1969; 1(3):247-59. PubMed ID: 4939635
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppression by chemical agents.
    Bach JF
    Transplant Proc; 1971 Mar; 3(1):27-33. PubMed ID: 4937894
    [No Abstract]   [Full Text] [Related]  

  • 13. [Correlation between lymphocytes and polyblast-macrophages and their cytologic characteristic during the use of antineoplastic agents].
    Korol'chuk VP; Iushkov SF
    Farmakol Toksikol; 1971; 34(2):213-9. PubMed ID: 5563396
    [No Abstract]   [Full Text] [Related]  

  • 14. Allogeneic marrow grafts in man using cyclophosphamide.
    Santos GW; Sensenbrenner LL; Burke PJ; Mullins GM; Anderson PN; Tutschka PJ; Braine HG; Davis TE; Humphrey RL; Abeloff MD; Bias WB; Borgaonkar DS; Slavin RE
    Transplant Proc; 1974 Dec; 6(4):345-8. PubMed ID: 4155151
    [No Abstract]   [Full Text] [Related]  

  • 15. [BONE MARROW, IMMUNOSUPPRESSIVE AGENTS AND ALLOGENIC TRANSPLANTATION].
    GROSJEAN O; OTTE H; PHILIPPART-DUPONT F
    C R Seances Soc Biol Fil; 1964; 158():2483-6. PubMed ID: 14289741
    [No Abstract]   [Full Text] [Related]  

  • 16. The induction of graft versus host disease in mice treated with cyclophosphamide.
    Owens AH; Santos GW
    J Exp Med; 1968 Aug; 128(2):277-91. PubMed ID: 4873022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marrow grafts between DL-A-matched canine littermates.
    Storb R; Rudolph RH; Kolb HJ; Graham TC; Mickelson E; Erickson V; Lerner KG; Kolb H; Thomas ED
    Transplantation; 1973 Jan; 15(1):92-100. PubMed ID: 4268054
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of fludarabine as an immunosuppressor for bone marrow transplantation conditioning: preliminary results.
    Terenzi A; Aristei C; Aversa F; Perruccio K; Chionne F; Raymondi C; Latini P; Martelli MF
    Transplant Proc; 1996 Dec; 28(6):3101. PubMed ID: 8962201
    [No Abstract]   [Full Text] [Related]  

  • 19. Allogeneic marrow transplants in cyclophosphamide treated mice.
    Santos GW; Owens AH
    Transplant Proc; 1969 Mar; 1(1):44-6. PubMed ID: 4400067
    [No Abstract]   [Full Text] [Related]  

  • 20. Histopathological changes in canine renal allotransplants after yeast respiratory extract (PCO) treatment.
    Groenewald JH; Weber HW; Mirand EA; Murphy GP
    Am Surg; 1971 May; 37(5):281-6. PubMed ID: 4930631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.